Biologic dose reduction in psoriasis: why would you? Prof Stephen Shumack

A study of biologic dose reduction in patients with stable psoriasis has found patients are not particularly worse off by increasing the interval between injections. The Dutch study published in JAMA Dermatology, which randomised 120 patients to either dose reduction or usual care, found  the mean difference in PASI scores at 12 months from baseline ...

Already a member?

Login to keep reading.

© 2021 the limbic